NATURAL PRODUCT RESEARCH
5
(
1H, dd, J ¼ 12.0, 11.9 Hz, H-1b), 4.23 (1H, m, H-2), 2.47 (1H, m, H-3), 1.34 (1H, m, H-3),
2
7
1
.67 (1H, m, H-4), 1.49 (1H, m, H-5), 1.93 (1H, m, H-6), 1.64 (1H, m, H-6), 1.69 (1H, m, H-
), 1.45 (1H, m, H-7), 1.06 (1H, br d, J ¼ 7.6 Hz, H-9), 1.62 (1H, m, H-11), 1.48 (1H, m, H-
1), 1.63 (1H, m, H-12), 1.47 (1H, m, H-12), 2.71 (1H, m, H-13), 1.87 (1H, br d, J ¼ 11.6,
H-14), 1.40 (1H, dd, J ¼ 11.6, 5.0 Hz, H-14), 3.76 (1H, s, H-15), 5.18 (1H, br s, H-17a), 5.08
0
(
8
1H, br s, H-17b), 1.00 (3H, s, H-20), 4.42 (1H, d, J ¼ 8.0 Hz, H-1 ), 3.12 (1H, dd, J ¼ 9.0,
0
0
0
.0 Hz, H-2 ), 3.35 (1H, dd, J ¼ 9.3, 9.0 Hz, H-3 ), 3.25 (1H, t, J ¼ 9.3 Hz, H-4 ), 3.47 (1H,
0
0
ddd, J ¼ 9.3, 6.5, 1.6 Hz, H-5 ), 4.46 (1H, dd, J ¼ 11.7, 1.6 Hz, H-6 ), 4.13 (1H, dd, J ¼ 11.7,
0
00
00
6
4
3
1
1
.5 Hz, H-6 ), 2.21 (2H, d, J ¼ 7.6 Hz, H-2 ), 2.07 (1H, m, H-3 ), 0.95 (3H, d, J ¼ 6.6 Hz, H-
0
0
00 13
), 0.95 (3H, d, J ¼ 6.6 Hz, H-5 ); C NMR (150 MHz, CD OD): d 49.0 (C-1), 74.3 (C-2),
3
5.7 (C-3), 44.8 (C-4), 50.5 (C-5), 26.7 (C-6), 36.3 (C-7), 48.9 (C-8), 54.5 (C-9), 41.9 (C-10),
9.4 (C-11), 33.8 (C-12), 43.8 (C-13), 37.3 (C-14), 83.6 (C-15), 160.4 (C-16), 109.2 (C-17),
0
0
0
0
0
79.0 (C-18), 17.4 (C-20), 103.4 (C-1 ), 75.2 (C-2 ), 78.0 (C-3 ), 71.9 (C-4 ), 75.3 (C-5 ), 64.7
0
00
00
00
00
00
(C-6 ), 174.7 (C-1 ), 44.3 (C-2 ), 27.0 (C-3 ), 22.9 (C-4 ), 22.9 (C-5 ).
2
-O-(2-O-isovaleryl-b-D-glucopyranosyl) atractyligenin (2): white amorphous powder;
2
5
ꢂ1
½
aꢄ þ 28.9 (c 0.1, MeOH); IR (KBr) vmax 3628, 2921, 1716, 1650 cm ; UV (MeOH) kmax
D
-
1
log(e) 201 (2.85) nm; HRESIMS m/z 579.3161 [M-H] (calcd 579.3169); H NMR (600 MHz,
CD OD): d 2.30 (1H, dd, J ¼ 12.0, 3.6 Hz, H-1a), 0.75 (1H, t, J ¼ 12.0 Hz, H-1b), 4.23 (1H,
3
m, H-2), 2.40 (1H, m, H-3), 1.20 (1H, m, H-3), 2.66 (1H, m, H-4), 1.45 (1H, m, H-5), 1.92
(1H, m, H-6), 1.64 (1H, m, H-6), 1.68 (1H, m, H-7), 1.44 (1H, m, H-7), 1.05 (1H, br d,
J ¼ 7.5 Hz, H-9), 1.62 (1H, m, H-11), 1.47 (1H, m, H-11), 1.63 (1H, m, H-12), 1.47 (1H, m,
H-12), 2.70 (1H, m, H-13), 1.87 (1H, m, H-14), 1.39 (1H, m, H-14), 3.76 (1H, s, H-15), 5.18
0
(
4
1H, br s, H-17a), 5.07 (1H, br s, H-17b), 0.99 (3H, s, H-20), 4.60 (1H, d, J ¼ 8.0 Hz, H-1 ),
0
0
.68 (1H, dd, J ¼ 9.0, 8.0 Hz, H-2 ), 3.50 (1H, dd, J ¼ 9.2, 9.0 Hz, H-3 ), 3.38 (1H, dd,
0
0
J ¼ 9.5, 9.2 Hz, H-4 ), 3.32 (1H, ddd, J ¼ 9.5, 5.3, 1.3 Hz, H-5 ), 3.85 (1H, dd, J ¼ 12.0,
0
0
00
1
2
.3 Hz, H-6 ), 3.69 (1H, dd, J ¼ 12.0, 5.3 Hz, H-6 ), 2.37 (1H, dd, J ¼ 14.8, 6.2 Hz, H-2 ),
0
0
00
00
.17 (1H, dd, J ¼ 14.8, 8.0 Hz, H-2 ), 1.88 (1H, m, H-3 ), 1.43 (1H, m, H-4 ), 1.24 (1H, m,
0
0
00
00 13
H-4 ), 0.97 (3H, d, J ¼ 6.7 Hz, H-5 ), 0.91 (3H, t, J ¼ 7.4 Hz, H-6 ); C NMR (150 MHz,
CD OD): d 48.8 (C-1), 74.1 (C-2), 35.8 (C-3), 44.7 (C-4), 50.6 (C-5), 26.7 (C-6), 36.3 (C-7),
3
4
9.0 (C-8), 54.5 (C-9), 41.9 (C-10), 19.8 (C-11), 33.7 (C-12), 43.8 (C-13), 37.3 (C-14), 83.6
0 0
(C-15), 160.4 (C-16), 109.1 (C-17), 178.9 (C-18), 17.3 (C-20), 101.1 (C-1 ), 75.2 (C-2 ), 76.4
0 0 0 0 00 00 00
(C-3 ), 71.8 (C-4 ), 78.0 (C-5 ), 62.7 (C-6 ), 174.1 (C-1 ), 42.6 (C-2 ), 33.3 (C-3 ), 30.5 (C-
0
0
00 00
), 19.3 (C-5 ), 11.8 (C-6 ).
4
3.5. Acid hydrolysis of 1 and 2
Each compounds (2.0 mg) was heated in 3 M CF COOH (3.0 mL) for 3 h in a
3
water bath. Each mixture was extracted three times with EtOAc. The aqueous layer
was evaporated to dryness with ethanol in vacuo until neutral. The residue was dis-
solved in pyridine (1.0 mL), and then added the L-cysteine methyl ester (1.0 mg) and
o-tolyisothiocyanate (1.0 mL) for derivatization. The reaction mixture was centrifuged
and precipitate was removed. Then the solution was analyzed by Water e2695 HPLC
system (CAPCELL PAK C-18 column), eluting with A (0.1% formic acid): B (acetonitrile)
ꢃ
¼
83: 17 (v/v) at 1.0 mL/min. The column temperature was set at 30 C and the